Who is developing and funding INTERVALS?

Philip Morris International R&D initiated the creation of INTERVALS with the intention to build an online platform enabling independent, third-party collaboration and data analysis by sharing protocols, tools, and data from assessment studies proactively. Data files are accompanied by the relevant information to foster reproducible research and by high-level summaries of obtained results. As the platform also hosts protocols and results from in vivo inhalation studies and in vitro studies describing the chemical composition, genotoxicity, cytotoxicity, and physical properties of the aerosol from this and other candidate and potential modified risk tobacco products, it can serve as an invaluable source of scientific assessment data. 
The site and associated data warehouse are developed in collaboration with Emakina and Douglas Connect GmbH.